Carsgen Therapeutics Limited (2171.HK) Q1 2024 Earnings

26MarConfirmed
Q2 2023
Q1 2024
-0.97
-0.87
-0.78
-0.68

Details

Expected EPS
-0.9696575988
Actual EPS
-0.6831678537
Surprise EPS
0.29
Surprise Percent
+29.55%

Description

Carsgen Therapeutics Limited (2171.HK) has reported earnings of -0.6831678537 per share for Q1 2024.

0 Comments

Share your thoughts